ELECTROLYTE IMBALANCES IN PATIENTS ADMITTED WITH CHEMOTHERAPY INDUCED FEBRILE NEUTROPENIA: PATTERNS AND IMPACT ON OUTCOMES. A SINGLE CENTER STUDY FROM PAKISTAN

被引：0
|
作者：
Bawany, Samira Ahmad
机构：
来源：
NEURO-ONCOLOGY | 2009年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：636 / 636
页数：1
相关论文
共 50 条
  • [31] Outcomes of Granulocyte Transfusion in Haematology Patients with Febrile Neutropenia - a Single Centre Retrospective Cross Sectional Study
    Jalajakumari, Gohul Gopi
    Ganapathy, Rema
    Shenoy, Veena
    John, Linda
    Unni, Manoj
    Haridas, Nikhil Krishna
    Vinayakumar, Syamprasad
    Yadav, Chitresh
    Agrawal, Shreya Gopal
    Yawalkar, Rashmi Suresh
    Pattnaik, Sandeep Abhijit
    Gopi, Vandana
    Sidharthan, Neeraj
    Ashya, Arif Vaheedu Abdulvahid
    Shaji, Ajil
    Kartha, Nivedhitha
    BLOOD, 2022, 140 : 11384 - 11385
  • [32] Evaluating the total costs of chemotherapy-induced febrile neutropenia: Results from a pilot study with community oncology cancer patients
    Bennett, Charles L.
    Calhoun, Elizabeth A.
    ONCOLOGIST, 2007, 12 (04): : 478 - 483
  • [33] Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (MONITOR-GCSF study)
    Aapro, M.
    Ludwig, H.
    Bokemeyer, C.
    Gascon, P.
    Boccadoro, M.
    Denhaerynck, K.
    Krendyukov, A.
    Gorray, M.
    MacDonald, K.
    Abraham, I.
    ANNALS OF ONCOLOGY, 2016, 27 (11) : 2039 - 2045
  • [34] Impact of UGT1A1 Polymorphisms on Febrile Neutropenia in Pancreatic Cancer Patients Receiving FOLFIRINOX: A Single-Center Cohort Study
    Keum, Jiyoung
    Lee, Hee Seung
    Jo, Jung Hyun
    Chung, Moon Jae
    Park, Jeong Youp
    Park, Seung Woo
    Song, Si Young
    Bang, Seungmin
    CANCERS, 2022, 14 (05)
  • [35] Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study) (vol 24, pg 911, 2016)
    Gascon, Pere
    Aapro, Matti
    Ludwig, Heinz
    Bokemeyer, Carsten
    Boccadoro, Mario
    Turner, Matthew
    Denhaerynck, Kris
    MacDonald, Karen
    Abraham, Ivo
    SUPPORTIVE CARE IN CANCER, 2016, 24 (02) : 927 - 927
  • [36] Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in solid tumours versus haematological malignancies: Patterns, outcomes and determinants (MONITOR-GCSF study)
    Aapro, M.
    Bokemeyer, C.
    Boccadoro, M.
    Gascon, P.
    Denhaerynck, K.
    Krendyukov, A.
    Abraham, I.
    Macdonald, K.
    Ludwig, H.
    ANNALS OF ONCOLOGY, 2017, 28
  • [37] Treatment patterns and outcomes in patients with non-small cell lung cancer (NSCLC) receiving biosimilar filgrastim for prophylaxis of chemotherapy-induced/febrile neutropenia: Results from the MONITOR-GCSF study
    Aapro, M.
    Krendyukov, A.
    Hobel, N.
    Gascon, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [38] IMPACT OF FEBRILE NEUTROPENIA ON RCHOP CHEMOTHERAPY DELIVERY AND HOSPITALIZATIONS: RESULTS FROM AN INTERNATIONAL OBSERVATIONAL STUDY IN PATIENTS WITH NON-HODGKIN LYMPHOMA (IMPACT NHL)
    Pettengell, R.
    Johnsen, H. E.
    Lugtenburg, P.
    Salar, A.
    Duehrsen, U.
    Haioun, C.
    Verhoef, G.
    Rossi, F.
    Schwenkglenks, M.
    Bendall, K.
    Szabo, Z.
    Jaeger, U.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 365 - 365
  • [39] The Impact of ABO Incompatibility on the Outcomes of Hematopoietic Stem Cell Transplantation: A Single-Center Study From Pakistan
    Borhany, Munira
    Ali, Muhammad Shujat
    Ghias, Zainab
    Abid, Madiha
    Zafar, Sidra
    Shamsi, Tahir
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [40] Outcomes of primary and secondary prophylaxis of chemotherapy-induced and febrile neutropenia in bendamustine plus rituximab regimens in patients with lymphoma and chronic lymphocytic leukemia: real-world, single-center experience
    Logan Moore
    Trace Bartels
    Daniel O. Persky
    Ivo Abraham
    Abhijeet Kumar
    Ali McBride
    Supportive Care in Cancer, 2021, 29 : 4867 - 4874
12345